- Home
- EFSC vs RCKT Comparison
EFSC vs RCKT Comparison
Compare EFSC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSC
- RCKT
- Stock Information
- Founded
- EFSC 1988
- RCKT 1999
- Country
- EFSC United States
- RCKT United States
- Employees
- EFSC N/A
- RCKT N/A
- Industry
- EFSC Major Banks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- EFSC Finance
- RCKT Health Care
- Exchange
- EFSC Nasdaq
- RCKT Nasdaq
- Market Cap
- EFSC 2.0B
- RCKT 326.4M
- IPO Year
- EFSC 1999
- RCKT N/A
- Fundamental
- Price
- EFSC $57.35
- RCKT $2.95
- Analyst Decision
- EFSC Strong Buy
- RCKT Buy
- Analyst Count
- EFSC 3
- RCKT 13
- Target Price
- EFSC $64.33
- RCKT $18.50
- AVG Volume (30 Days)
- EFSC 198.7K
- RCKT 4.3M
- Earning Date
- EFSC 07-21-2025
- RCKT 08-04-2025
- Dividend Yield
- EFSC 2.09%
- RCKT N/A
- EPS Growth
- EFSC 9.23
- RCKT N/A
- EPS
- EFSC 5.09
- RCKT N/A
- Revenue
- EFSC $619,222,000.00
- RCKT N/A
- Revenue This Year
- EFSC $14.06
- RCKT N/A
- Revenue Next Year
- EFSC $4.85
- RCKT N/A
- P/E Ratio
- EFSC $11.27
- RCKT N/A
- Revenue Growth
- EFSC 6.50
- RCKT N/A
- 52 Week Low
- EFSC $38.88
- RCKT $2.19
- 52 Week High
- EFSC $63.13
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- EFSC 67.59
- RCKT 41.69
- Support Level
- EFSC $54.42
- RCKT $2.40
- Resistance Level
- EFSC $56.65
- RCKT $2.70
- Average True Range (ATR)
- EFSC 1.12
- RCKT 0.21
- MACD
- EFSC 0.36
- RCKT 0.15
- Stochastic Oscillator
- EFSC 95.43
- RCKT 73.53
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.